Stay updated on ABP 980 vs Trastuzumab in HER2+ Early Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the ABP 980 vs Trastuzumab in HER2+ Early Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABP 980 vs Trastuzumab in HER2+ Early Breast Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T13:49:12.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study information regarding a clinical trial for ABP 980 in breast cancer, while adding a new EudraCT number and a revision update.
    Difference
    17%
    Check dated 2025-04-16T01:35:57.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-08T19:58:10.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T13:38:43.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T17:18:10.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T09:08:56.000Z thumbnail image

Stay in the know with updates to ABP 980 vs Trastuzumab in HER2+ Early Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABP 980 vs Trastuzumab in HER2+ Early Breast Cancer Clinical Trial page.